Subscribe

145 - Bristol-Myers Squibb

Regis Duvignau — Reuters

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Key Metrics & Financials (Last Fiscal Year)

Previous Rank147
Revenues ($M)$20776
Revenue Percent Change6.9%
Profits ($M)$1007.0
Profits Percent Change-77.4%
Assets ($M)$33551
Market Value — as of March 29, 2018 ($M)$103415
Employees23700

More from FORTUNE

Company Facts

Employees23700
SectorHealth Care
IndustryPharmaceuticals
HQ LocationNew York City
CEOGiovanni Caforio
CEO Title-
Websitewww.bms.com
Years on Fortune 500 List24

See Full List

Outbrain

More from FORTUNE